INDV
Indivior Pharmaceuticals, Inc.
36.30$
+2.6%
vs. previous close
Closing price · As of: Nov 2, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Indivior Pharmaceuticals, Inc. (INDV) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 11/02/2026 | Current report (8-K) | Indivior Pharmaceuticals, Inc. (INDV): Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; Fin | View report ↗ |
| 10/29/2026 | Current report (8-K) | Indivior Pharmaceuticals, Inc. (INDV): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 10/15/2026 | Current report (8-K) | Indivior Pharmaceuticals, Inc. (INDV): Submission of Matters to a Vote of Security Holders | View report ↗ |
| 10/06/2026 | Current report (8-K) | Indivior Pharmaceuticals, Inc. (INDV): Other Events | View report ↗ |
| 09/30/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 09/17/2026 | Current report (8-K) | Indivior Pharmaceuticals, Inc. (INDV): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
| 09/15/2026 | Current report (8-K) | Indivior Pharmaceuticals, Inc. (INDV): Termination of a Material Definitive Agreement; Financial Statements and Exhibits | View report ↗ |
| 08/03/2026 | Current report (8-K) | Indivior Pharmaceuticals, Inc. (INDV): Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/03/2026 | Current report (8-K) | Indivior Pharmaceuticals, Inc. (INDV): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/03/2026 | Current report (8-K) | Indivior Pharmaceuticals, Inc. (INDV): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 07/10/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.